Clinical phenotypes of COPD;Fenotipos clínicos de la EPOC

Archivos de Bronconeumologia

Volumn 46, Issue SUPPL.11, 2010, Pages 8-11

  Sobradillo, Patricia ^a   García Aymerich, Judith ^b,c,d,e   Agustí, Àlvar ^a,f,g,h  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

^f Fundacion Caubet CIMERA   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Chronic bronchitis; Emphysema; Inflammation

Indexed keywords

ARTICLE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DISEASE EXACERBATION; HUMAN; OUTCOME ASSESSMENT; PHENOTYPIC VARIATION; PROGNOSIS; TREATMENT PLANNING; TREATMENT RESPONSE;

ACUTE DISEASE; BRONCHITIS, CHRONIC; CARDIOVASCULAR DISEASES; CLUSTER ANALYSIS; COHORT STUDIES; DISEASE PROGRESSION; HOSPITALIZATION; HUMANS; PHENOTYPE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SPAIN; TREATMENT OUTCOME;

EID: 79851482154     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S0300-2896(10)70056-9     Document Type: Article

References (28)

1. Rabe K F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555.
2. Peces-Barba G., Barberá J.A., Agustí A., Casanova C., Casas A., Izquierdo J.L., et al. Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT). Arch Bronconeumol 2008, 44:271-281.
3. Peces-Barba G, Barberá JA, Agustí, Casanova C, Casas A, Izquierdo JL, et al. Guía clínica de diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica. SEPAR-ALAT; 2007.
4. Agustí A.G. COPD, a multicomponent disease: implications for management. Respir Med 2005, 99:670-682.
5. Agustí A., Calverley P., Celli B., Coxson H., Edwards L., Lomas D., et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respiratory Research 2010, 11:122-136.
6. Rennard S.I., Vestbo J. The many " small COPDs": COPD should be an orphan disease. Chest 2008, 134:623-627.
7. García-Aymerich J, Gómez F, Benet M, Farrero E, Basagana X, Gayete A, et al. Identification and prospective validation of clincally relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax. En prensa 2010.
8. Vestbo J., Anderson W., Coxson H.O., Crim C., Dawber F., Edwards L., et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008, 31:869-873.
9. Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J. En prensa 2010.
10. Cho M.H., Washko G.R., Hoffmann T.J., Criner G.J., Hoffman E.A., Martínez F.J., et al. Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation. Respir Res 2010, 11:30.
11. Regan E.A., Hokanson J.E., Murphy J.R., Make B., Lynch D.A., Beaty T.H., et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010, 7:32-43.
12. Freimer N., Sabatti C. The human phenome project. Nat Genet 2003, 34:15-21.
13. Agustí A, Sobradillo P, Celli B. Addressing the complexity of COPD: from phenotypes and biomarkers to scale-free networks, systems biology and P4 medicine. Am J Respir Crit Care Med. En prensa 2010.
14. Han M.K., Agustí A., Calverley P.M., Celli B.R., Criner G., Curtis J.L., et al. Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD. Am J Respir Crit Care Med 2010, 182:598-604.
15. Vestbo J., Rennard S. Chronic obstructive pulmonary disease biomarker(s) for disease activity needed-urgently. Am J Respir Crit Care Med 2010, 182:863-864.
16. Marsh S.E., Travers J., Weatherall M., Williams M.V., Aldington S., Shirtcliffe P.M., et al. Proportional classifications of COPD phenotypes. Thorax 2008, 63:761-767.
17. Bhattacharya S., Srisuma S., DeMeo D.L., Shapiro S.D., Bueno R., Silverman E.K., et al. Molecular biomarkers for quantitative and discrete COPD phenotypes. Am J Respir Cell Mol Biol 2009, 40:359-367.
18. Jones P.W., Agusti A.GN. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 2006, 27:822-832.
19. Dornhorst A.C. Respiratory insufficiency. Lancet 1995, 268:1185-1187.
20. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981, 681-685. Report of the Medical Research Council Working Party, i.
21. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. A clinical trial. Ann Intern Med 1980, 93:391-398. Nocturnal Oxygen Therapy Trial Group.
22. Górecka D., Gorzelak K., Sliwinski P., Tobiasz M., Zielinski J. Effect of long term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 1997, 52:674-679.
23. Zielinski J. Long-term oxygen therapy in COPD patients with moderate hypoxaemia: does it add years to life?. Eur Respir J 1998, 12:756-758.
24. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003, 348:2059-2073. National Emphysema Treatment Trial Research Group.
25. Fabbri L.M., Calverley P.M., Izquierdo-Alonso J.L., Bundschuh D.S., Brose M., Martínez F.J., et al. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet 2009, 374:695-703.
26. Calverley P.M., Rabe K.F., Goehring U.M., Kristiansen S., Fabbri L.M., Martínez F.J. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 2009, 374:685-694.
27. García-Aymerich J., Gómez F.P., Antó J.M. Phenotypic characterization and course of chronic obstructive pulmonary disease in the PAC-COPD study: design and methods. Arch Bronconeumol 2009, 45:4-11.
28. Hurst J.R., Vestbo J., Anzueto A., Locantore N., Ullerova H., Tal-Singer R., et al. 2010. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010, 363:1128-1138.